The observed high prevalence and prognostic specificity of different expression‐related alterations at TERT‐locus, and the exclusive co‐existence of these events in our series of clinically aggressive tumours, evidences that TERT‐locus is a critical susceptibility site for tumour progression in thyroid cancer. This evidence concerns the gene TERT and thyroid cancer.